The Valley Hospital is a 451-bed, acute-care, not-for-profit hospital in Ridgewood, Bergen County, New Jersey. Valley staff includes more than 1,100 physicians, 3,700 employees and 3,000 volunteers. In 2020, Valley recorded 41,345 admissions, 51,792 emergency department visits and 3,528 births.

There are 451 beds in The Valley Hospital.

During the past decade, The Valley Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 9 clinical trials were completed, i.e. on average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 7 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Valley Hospital" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Daiichi Sankyo, Inc." with 2 trials sponsored, "Valley Health System" with 2 trials sponsored, "AB Science" with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Valley Hospital" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Sellas Life Sciences Group" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Agenus Inc." with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "The Valley Hospital" are "Breast Cancer" (4 trials), "Atrial Fibrillation" (3 trials), "Non-Small Cell Lung Cancer" (2 trials), "Advanced Breast Cancer" (1 trials) and "Brain and Central Nervous System Tumors" (1 trials). Many other conditions were trialed in "The Valley Hospital" in a lesser frequency.

Most popular intervention types in "The Valley Hospital" are "Drug" (16 trials), "Biological" (4 trials), "Device" (3 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Atezolizumab" (3 trials), "Carboplatin" (2 trials), "GM-CSF" (2 trials) and "Gemcitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Valley Hospital" are 18 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "The Valley Hospital". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in The Valley Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Valley Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".